August 28, 2008
Pfizer Launches New Bladder Drug
Pfizer has launched Toviaz, a new once daily treatment for the symptoms of overactive bladder.
Toviaz (fesoterodine) is available as a 4mg and 8mg prolonged-release tablet. In trials, initial treatment effect was seen as early as two weeks after the start of therapy with fesoterodine. In addition, the medicine was generally well tolerated.
Fesoterodine is an antimuscarinic drug which works by relaxing the muscles found in the wall of the bladder, decreasing sudden uncontrollable bladder contractions and increasing bladder capacity.